High Vista Strategies LLC Pfizer Inc Transaction History

High Vista Strategies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $1.52 Million - $1.78 Million	60,300 New	60,300 $1.69 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $225,000 - $247,200	-6,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $184,656 - $210,528	-4,800 Reduced 44.44%	6,000 $262,000
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $44,811 - $54,353	1,300 Added 13.68%	10,800 $476,000
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $6,595 - $7,031	-200 Reduced 2.06%	9,500 $345,000
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $15,955 - $18,510	-500 Reduced 4.9%	9,700 $344,000
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $129,713 - $137,631	-3,900 Reduced 27.66%	10,200 $369,000
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $437,100 - $481,515	14,100	14,100 $503,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.